Related Experiment Video
Updated: Jun 25, 2026
08:50
Analysis of Beta-cell Function Using Single-cell Resolution Calcium Imaging in Zebrafish Islets
Published on: July 3, 2018
The beta cell population in type 1 diabetes.
Daniel Pipeleers1, Peter In't Veld, Miriam Pipeleers-Marichal
1Diabetes Research Center at Brussels Free University-VUB, JDRF Center for Beta Cell Therapy in Diabetes, Laarbeeklaan 103, 1090 Brussels, Belgium.
Novartis Foundation Symposium
|February 11, 2009
Summary
Type 1 diabetes involves significant beta cell loss at diagnosis. This study examines if autoimmune destruction continues in remaining beta cells and newly formed ones, using patient pancreas data.
Area of Science:
- Immunology
- Endocrinology
- Pathology
Background:
- Type 1 diabetes is characterized by autoimmune destruction of insulin-producing beta cells.
- The prevailing view suggests over 90% beta cell loss at clinical onset.
Purpose of the Study:
- To evaluate the extent of beta cell destruction in type 1 diabetes.
- To investigate ongoing autoimmune reactivity against beta cells and their potential for regeneration or replacement.
Main Methods:
- Histological examination of pancreatic tissue from type 1 diabetic patients.
- Analysis of pancreatic tissue from antibody-positive non-diabetic organ donors.
Main Results:
- The study's findings on the extent of beta cell destruction and ongoing autoimmune processes will be detailed here.
- Results will clarify whether newly formed or implanted beta cells are also targeted.
Conclusions:
- The findings will challenge or support the traditional view of type 1 diabetes pathogenesis.
- This research offers insights into the dynamics of beta cell autoimmunity and potential therapeutic targets.
Related Concept Videos
01:26Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
01:12Type I Diabetes I: Introduction
Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
01:24Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
01:36Carbohydrate Metabolism
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in the...
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in the...
01:22Diabetes Mellitus: Overview and Type I Subtype
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
01:26Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...